MedWatch

Entrepreneurs raise DKK 10 million to help sperm quality test penetrate lucrative US market

Valby-based company Motilitycount, which obtained FDA approval for its sperm quality test last year, has raised DKK 10 million (USD 1.4 million) through new investors and debt conversion. The money makes it possible for the company to go from being a startup to a scaleup firm, the CEO says.

Mogens C. Thomsen, CEO of Motilitycount. | Foto: Motilitycount / PR

Avoid a trip to the doctor or fertility clinic.

Motilitycount, which is a startup based in Copenhagen, wants to spin gold in the USA from its home testing kit for sperm quality in humans, and in time, animals.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Sanofi dropper udvikling af mRNA-vaccine mod covid-19

Moderna samt Pfizer og Biontech har sat sig så effektivt på markedet for mRNA-vacciner mod covid-19, at Sanofi nu dropper selskabets kandidat inden for samme teknologi - satser i stedet på mere traditionel vaccine-teknologi.

Trial banner

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier